31
|
|
|
Lysosomal associated membrane protein family member 5 |
BAD-LAMP, BADLAMP, C20orf103, LAMP-5, UNC-46 |
|
32
|
|
|
Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 |
ENDAP, HSPC003, MAPBPIP, MAPKSP1AP, ROBLD3, Ragulator2, p14 |
|
33
|
|
|
Late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 |
MAP2K1IP1, MAPBP, MAPKSP1, MP1, PRO0633, Ragulator3 |
|
34
|
|
|
Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 |
C7orf59 |
|
35
|
|
|
Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 |
HBXIP, XIP |
|
36
|
|
|
LanC like glutathione S-transferase 1 |
GPR69A, p40 |
|
37
|
|
|
LanC like glutathione S-transferase 2 |
GPR69B, TASP |
|
38
|
|
|
Leucine aminopeptidase 3 |
HEL-S-106, LAP, LAPEP, PEPS |
|
39
|
|
|
Lysosomal protein transmembrane 5 |
CLAST6 |
|
40
|
|
|
LARGE xylosyl- and glucuronyltransferase 1 |
LARGE, MDC1D, MDDGA6, MDDGB6 |
Amphetamine or sympathomimetic abuse, Congenital muscular dystrophy due to dystroglycanopathy, Congenital muscular dystrophy, Congenital myopathy, Liver neoplasms, Major depressive disorder, Metabolic syndrome, Muscle eye brain disease, Muscular dystrophy, Neurotic disorder, Oligodendroglioma, Retinitis pigmentosa, Schizophrenia, Scoliosis, Diabetes mellitus type 2, Walker-warburg syndromeView all (1 more) |